Brain Barriers as Targets in Pathologies and Therapy

Maria       Deli; Andrej       Kovac

doi:10.2174/138161282613200506134601

[1] 
Toth AE, Holst MR, Nielsen MS. Vesicular transport machinery in brain endothelial cells: what we know and what we do not. Curr Pharm Des  2020; 26(13): 1405-16.
[2] 
Curtaz CJ, Schmitt C, Blecharz-Lang KG, Roewer N, Wöckel A, Burek M. Circulating MicroRNAs and blood-brain-barrier function in breast cancer metastasis. Curr Pharm Des  2020; 26(13): 1417-27.
[3] 
de Trizio I, Errede M, d’Amati A, Girolamo F, Virgintino D. Expression of P-gp in glioblastoma: what we can learn from brain development. Curr Pharm Des  2020; 26(13): 1428-37.
[4] 
Banks WA. The blood-brain barrier interface in diabetes mellitus: dysfunctions, mechanisms, and approaches to treatment. Curr Pharm Des  2020; 26(13): 1438-47.
[5] 
Hanes J, Dobakova E, Majerova P. Brain drug delivery: overcoming the blood-brain barrier to treat tauopathies. Curr Pharm Des  2020; 26(13): 1448-65.
[6] 
Morofuji Y, Nakagawa S. Drug development for central nervous system diseases using in vitro blood-brain barrier models and drug repositioning. Curr Pharm Des  2020; 26(13): 1466-85.
[7] 
Tóth ME, Dukay B, Hoyk Z, Sántha M. Cerebrovascular changes and neurodegeneration related to hyperlipidemia: characteristics of the human apob-100 transgenic mice. Curr Pharm Des  2020; 26(13): 1486-94.
[8] 
Cavaco M, Valle J, da Silva R, et al. DPepH3, an improved peptide shuttle for receptor-independent transport across the blood-brain barrier. Curr Pharm Des  2020; 26(13): 1495-506.

Rights & Permissions Print Cite

Article Metrics

31

3

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/138161282613200506134601	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

Current Pharmaceutical Design

Brain Barriers as Targets in Pathologies and Therapy

Related Journals

Related Books